Jianjun Li
- Co-authors
- Houjie LiangGanfeng XieZhenyu DingJingtao TongLiang‐Liang ChenFeng PanLan ZouYanling Zhang
- Topics
- MicroRNA in disease regulation (11 papers)Cancer-related molecular mechanisms research (11 papers)Cancer, Hypoxia, and Metabolism (7 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Jianjun Li
30 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Molecular Biology 684
- Cancer Research 671
- Oncology 224
- Pulmonary and Respiratory Medicine 113
- Surgery 88
Countries citing papers authored by Jianjun Li
This map shows the geographic impact of Jianjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Li more than expected).
Fields of papers citing papers by Jianjun Li
This network shows the impact of papers produced by Jianjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Li. The network helps show where Jianjun Li may publish in the future.
Co-authorship network of co-authors of Jianjun Li
This figure shows the co-authorship network connecting the top 25 collaborators of Jianjun Li. A scholar is included among the top collaborators of Jianjun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjun Li. Jianjun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 15 | |
| 3 | Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancersbreakdown → | 54 |
| 4 | 18 | |
| 5 | 7 | |
| 6 | 6 | |
| 7 | 95 | |
| 8 | 40 | |
| 9 | 17 | |
| 10 | 27 | |
| 11 | 13 | |
| 12 | 28 | |
| 13 | 4 | |
| 14 | 19 | |
| 15 | 138 | |
| 16 | 81 | |
| 17 | 87 | |
| 18 | 85 | |
| 19 | 88 | |
| 20 | 29 |
About Jianjun Li
Jianjun Li is a scholar working on Cancer Research, Molecular Biology and Biophysics, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Cancer Research (671 citations), Molecular Biology (684 citations) and Oncology (224 citations). Jianjun Li has collaborated with scholars based in China and United States. Frequent co-authors include Houjie Liang, Ganfeng Xie, Zhenyu Ding, Jingtao Tong, Liang‐Liang Chen, Feng Pan, Lan Zou, Yanling Zhang, Jianfang Chen and Feng Pan. Their work appears in journals such as PLoS ONE, Scientific Reports and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.